This action by the Securities and Exchange Commission (SEC) in the District Court for the Southern District of New York arises from an offering of 50,000 units of common stock and redeemable purchase warrants of Beneficial Labs, Inc. (BL) made by Commonwealth Chemical Securities, Inc. (CCS) on a “best efforts — all or none basis,” and an additional 50,000 units on a “best efforts” basis in the go-go market of late 1971 and early 1972. The offering circular, issued pursuant to SEC Regulation A under the Securities Act of 1933, must be read to be believed. It described BL as having 250,000 outstanding shares of common stock, 236,000 of which were owned by officers and directors. 1 In contrast to this impressive capitalization BL had net tangible *93 assets of $4,750 or 2<t per share. If the minimum of 50,000 units had been sold at the offering price of $2.25 per share, BL, after paying underwriting commissions to CCS and other expenses, would have had net tangible assets of $83,500 or 28<p per share. The result, all clearly stated in the Offering Circular, would have been to increase the equity of existing shareholders from 2<p to 28<p per share, whereas the purchasers’ investment of $2.25 per unit would have dwindled to the same amount. The rare opportunity offered as an inducement was that BL, which had engaged in no business and had no corporate headquarters aside from Feldman’s residence, intended “to own and operate pharmacies and to operate drug departments in larger units such as department stores and supermarkets” and also “to sell in its pharmacies certain items which it will purchase at wholesale and bottle and sell under its own label.” To that end, approximately $25,000 would be allocated to working capital “including officer’s salary and general overhead,” with $53,750 left available “to make cash down payments on the purchase of pharmacies.” The circular did not claim any originality in BL’s concepts; on the contrary it conceded, with elaborate detail, that BL “will be faced with very strong competition in its proposed operations.” Executives of the many great drug chains of the country or owners of established neighborhood drugstores would hardly have stirred in their sleep at the threat of BL’s prospective entry.
The SEC’s complaint had three main facets. The first was that although the Offering Circular dated December 20, 1971 had stated:
At least 50,000 units offered hereby must be sold and paid for or all subscription payments shall be promptly refunded in full without interest.
CCS closed the transaction on the basis of a declaration that 50,650 units had been sold and paid for by March 8, 1972 when in truth and fact they had not been. Here the SEC’s major item of evidence was the purported sale of 2,000 units each to four friends of a CCS employee avowedly as nominees for one David Massad in Boston; the units were not paid for before the closing and Drucker repurchased them from Massad two or three weeks thereafter. The second facet was that thereafter the defendants embarked on a course of manipulating BL stock by a campaign of buying and selling which drove the price of BL common stock up to a range of 14-15 by the end of September 1972 and a high of 241/2 on January 15, 1973 — representing a market value of $7,365,925.
Here the SEC’s principal item of evidence was the testimony of a SEC analyst that accounts controlled by the defendants participated in extraordinarily large percentages of all transactions in BL stock, warrants and units — plus the fact that prices rose astronomically although BL reported no earnings through September 1972 and the offering circular had conceded that BL could commence business only on a small scale if only 50,000 units were sold and that failure to sell all 100,000 units might severely limit “the potential of the Company.” On March 5, 1973, the SEC suspended trading. When it allowed trading to be resumed on October 31, 1973, there were no reported bids for the stock; in November 1973, two of the mutual funds hereafter mentioned sold their BL stock at prices which, after giving effect to a 100% stock dividend, were less than $1 per share.
Some of the allegedly manipulative transactions were with investment companies to which some defendants were “affiliates” as defined in § 2(a)(2), (3) of the Investment Company Act or an investment adviser as defined in § 2(a)(20) of that Act and § 202(a)(ll) of the Investment Advisers Act. These transactions, along with several others, form the basis for the third facet of the SEC complaint, alleging violations of §§ 17(a), 36(a), 37, and 48(a) of the Investment Company Act and § 206(1) and (2) of the Advisers Act. The funds to which some . of the defendants were affiliates and advisers were induced to purchase 22,100 shares of BL common and 3,000 warrants at a total cost of $220,137.50 and an ultimate loss of $158,345.
*94 The appellants here are CCS; Robert Drucker, vice president and a director of CCS and owner of Vi of its shares as well as xh of the shares of a corporation owning lh of the CCS stock, who at the time of the alleged violations was an officer and director of Vanguard Fund, Inc. (Vanguard) and New York Hedge Fund (Hedge) and president and a director of DK&B Management, Inc. (DK&B); Julius Kleinman, president, treasurer and chairman of the board of directors of CCS, who at the time of the alleged violations was an officer and director of Hedge and Vanguard and vice president, secretary and a director of DK&B; DK&B, which was the registered investment adviser of Hedge from October 24, 1972 to September 22, 1973 and of Vanguard from March 22, 1972 to July 16, 1973; Mary Sharpe, CCS’s bookkeeper from August 1970 to June 1974; and Marlene Klein-man, Kleinman’s wife. The district court ruled in favor of the SEC on all three of its claims. Specifically it found that the minimum of 50,000 units provided for in the offering had not in fact been sold and that in consequence CCS, Drucker and Kleinman had violated § 17(a) of the 1933 Act, § 10(b) of the 1934 Act and Rules 10b-5 2 and lob-6, § 15(c)(2) of the 1934 Act and Rule 15c2-4, 3 and with DK&B, §§ 17(a), 48(a), 36(a) and 37 of the Investment Company Act; that the same defendants and DK&B had violated § 17(a) of the 1933 Act and § 10(b) of the 1934 Act and Rule 10b-5 for manipulating the market in BL shares; that CCS, aided and abetted by Drucker, Kleinman and Sharpe violated SEC bookkeeping rules under the 1934 Act, notably Rule 17a-3(a)(9), since the records reflected fictitious ownership of securities; that DK&B, aided and abetted by Drucker and Kleinman, violated § 206(1) and (2) of the Investment Advisers Act; that Sharpe also violated § 17(a) of the 1933 Act and § 10(b) of the 1934 Act and Rule 10b-5 for her role in the fraudulent closing and the market manipulation; and that Mrs. Kleinman violated these same provisions for her role in the market manipulation. Accordingly it granted the SEC’s prayers for an injunction and disgorgement of profits.
Appellants attack these rulings on innumerable grounds. Some of these raise important and recurring issues of law and two raise arguable questions of the sufficiency of evidence. We shall limit ourselves to the points which we believe to merit discussion by us; for the balance we rest on the excellent opinion of Judge MacMahon.
DISCUSSION
I. Defendants’ asserted right to a jury trial.
Defendants had made the jury demand required by F.R.Civ.P. 38(b). The judge *95 struck it sua sponte. This, appellants claim, was error.
The claim seems surprising since it has been assumed for decades that a suit for an injunction, whether by the Government or a private party, was the antithesis of a suit “at common law” in which the Seventh Amendment requires that the right to trial by jury “shall be preserved.” In 1791, when the Seventh Amendment became effective, injunctions, both in England and in this country, were the business of courts of equity, not of courts of common law. Although the entitlement to a jury trial extends to many rights that were not recognized in 1791, e. g., the special liability of the seller of a product for physical harm to a user or consumer, see ALI, Restatement of Torts 2d, § 402A (1965), or an action for damages based upon a statute creating a tort unknown to the common law, see,
Curtis
v.
Loether,
The first is that the SEC’s demand was not simply for an injunction but also for disgorgement of profits; . indeed it would probably not be going too far to suppose that in this case the SEC was more interested in the latter remedy than in the former. On appellants’ view, money is money, whether it be characterized as damages or disgorgement. But while injunctions were the exclusive business of equity, it was never true that money claims were totally excluded from its jurisdiction. Actions against a trustee for breach of trust,
Nedd
v.
United Mineworkers of America,
Prior to the adoption of the Rules [of Civil Procedure], and for two decades after their adoption it was generally held that if a claim was properly equitable in character, there was no right to a jury trial on an issue of damages incidental to the equitable relief that the plaintiff sought.
See
Camp v. Boyd,
It is clear, however, that this received learning has been greatly impaired by
Dairy Queen, Inc. v. Wood,
On the other hand, not all money claims are triable to a jury. A historic equitable remedy was the grant of restitution “by which defendant is made to disgorge ill-gotten gains or to restore the status quo, or to accomplish both objectives.” See 5
Moore, supra,
¶ 38.24[2] at 190.5, and
Porter v. Warner Holding Co., supra,
*96
This view is consistent with recent judicial pronouncements. In
Curtis v. Loether, supra,
Nor is there any sense in which the award here can be viewed as requiring the defendant to disgorge funds wrongfully withheld from the plaintiff.
While from the standpoint of a defendant in an action for violation of the' securities laws there may be no great difference between paying money in response to a private suit for damages and in a SEC action for injunction and disgorgement wherein the SEC makes the proceeds of disgorgement available to injured parties, the suit by the SEC is decidedly more analogous to the traditional jurisdiction of equity to award restitution. Its availability is entrusted to the discretion of the court, a factor that has been considered significant in the resolution of the question whether back pay awards in discrimination cases are equitable or legal in nature. See
Curtis
v.
Loether, supra,
Defendants’ second argument for a jury trial is that, under our recent decision in
Shore v. Parklane Hosiery Co.,
Thus Beacon Theatres simply asserts that where parties join legal and equitable claims arising out of the same transaction, the court must schedule the sequence of trials to protect a party’s constitutional right to a jury trial.
Neither
Beacon Theatres
nor its subsequent extension in
Dairy Queen, Inc. v. Wood, supra,
II. Sufficiency of the evidence.
The only claims of insufficiency of the evidence that merit discussion are those on behalf of Mary Sharpe and Marlene Klein-man.
Sharpe, who was CCS’s bookkeeper, opened an account at the firm before the termination of the offering in the name of her mother, Nellie Pyles, and purchased 500 units on January 4, 1972, and 500 more on March 8, 1972, allegedly paying the $2250 price with cash she had kept at home and intending to give her mother any profits. On March 17, 1972, she sold 500 of these units at 2%, had a check issued in her mother’s name, endorsed it, and deposited the funds in her own checking account. She explained her failure to give her mother the small profits on the basis that they had had a dispute, the nature of which she could no longer recall. The judge disbelieved this story and found that Sharpe’s alleged purchase for her mother was not
bona fide
and that she “was knowingly attempting to aid and participate in the fraudulent closing of the offering, with some stake in its success . . . .”
The court’s conclusion was not clearly erroneous. Assuming that Sharpe could lawfully have made a bona fide purchase for herself or, as counsel for CCS had advised her, for her mother, the judge was warranted in concluding that she did neither. Rather she used her own funds to add what looked like a public purchase to the list in an amount which was significant to the target quantity for the distribution, and this just at the time when the principal defendants were using dummy nominees for the same purpose.
We have more difficulty with the court’s finding that this same evidence supports the conclusion that Sharpe was implicated in the subsequent manipulation. While her position as bookkeeper may have made her aware of what was going on, there is no evidence that she did anything to forward this, except for two small pieces of evidence which we have hit upon in our review of certain charts submitted by the SEC but which were never mentioned by anyone either at the trial or on this appeal. The charts show that on the same day, March 17,1972, when Mary Sharpe sold 500 shares from the Nellie Pyles account at 2%, she bought 500 shares for her own account at
*98
2%. If these were the same shares, the purported sale and purchase would have been unreal, since there is no evidence that Nellie Pyles knew about her account at that time. Whether or not they were the same, it would be hard to ascribe the decisions to investment judgment. The charts also show that Ms. Sharpe sold 50 units on November 21, 1972 and 150 shares of common stock on February 15, 1973, at prices reflecting the manipulative activity. If the SEC had made some point of these transactions in its direct presentation or in cross-examining Ms. Sharpe, we might have a different case,
5
but we do not think it fair to consider against Ms. Sharpe evidence which she had no opportunity to explain. If we ignore these transactions, all that is left is the sale of 500 shares at a small profit at the very beginning of the period of alleged manipulations. This is not enough. It may well be, as the district court found, that Ms. Sharpe must have known of the fraudulent manipulations of the other defendants, but that would not constitute manipulation on her part. Nor can we discern from this record how Sharpe’s transactions “more or less, coincided with the manipulations of Drucker and Kleinman,”
The evidence with respect to Marlene Kleinman’s participation in the manipulation is likewise not too impressive. The chief item is that on October 17,1972, under an alias she bought 100 units from a broker at 33, only six minutes after CCS had sold them to the same broker at 32%. The SEC argues there was no reason for her to pay an extra $25, plus a commission, for units which she could have bought directly from CCS. She also bought 500 units for 35 on November 20,1972 and sold them to CCS at 357/16 on January 10,1973. The SEC sought to eke out this rather meagre evidence with Mrs. Kleinman’s failure to testify and the adverse inference that could be drawn therefrom, see
N. Sims Organ & Co. v. SEC,
III. The appropriateness of an injunction.
Appellants argue that even if they were properly found to have violated the securities laws, it was inappropriate for the court to have issued an injunction. They contend that none of them has any history or pattern of securities violations; that this action was commenced 15 months and the injunction was imposed more than three and a half years after the last violation; that Kleinman and Drucker had not long been in the securities business, had voluntarily terminated all connection with it long before the injunction issued, and by virtue of agreements with the SEC cannot return to it without the consent of the regulatory agencies involved; and that the prospects of future violations by Ms. Sharpe and Mrs. Kleinman are even less. The SEC responds that appellants’ violations were repeated *99 over the course of a year, that Drucker and Kleinman do have a history of securities violations, and that Drucker’s and Klein-man’s consent to a Commission order to stay out of the securities industry is a much weaker safeguard against a securities violation than an injunction. In addition, the Commission cites a chorus of cases, including many of our own, saying as stated in SEC v. Manor Nursing Centers, Inc., supra, 458.F.2d at 1100, that
[A] district court has broad discretion to enjoin possible future violations of law where past violations have been shown, and the court’s determination that the public interest requires the imposition of a permanent restraint should not be disturbed on appeal unless there has been a clear abuse of discretion.
It is fair to say that the current judicial attitude toward the issuance of injunctions on the basis of past violations at the SEC’s request has become more circumspect than in earlier days.' Experience has shown that an injunction, while not always a “drastic remedy” as appellants contend, often is much more than the “mild prophylactic” described by the dissenters in this court in
SEC v. Capital Gains Research Bureau, Inc.,
Despite this we have no difficulty in sustaining the injunction with respect to the principal defendants here. Judge MacMahon, referring to Judge Tenney’s opinion in
SEC v. Universal Major Industries,
CCH Fed.Sec.L.Rep. ¶ 95,229 at 98,214 (S.D.N.Y.1975), later to be affirmed by this court,
the fact that defendant has been found liable for illegal conduct; the degree of scienter involved; whether the infraction is an “isolated occurrence;” whether defendant continues to maintain that his past conduct was blameless; and whether, because of his professional occupation, the defendant might be in a position where future violations could be anticipated.
We take a different view of the propriety of an injunction with respect to Ms. Sharpe and Mrs. Kleinman. Since we have held the evidence was insufficient to find that Ms. Sharpe engaged in or aided and abetted the manipulation, there is no basis for enjoining her with respect to conduct of that sort. Even as to the unlawful closing, we see no likelihood of repetition. Her participation in the closing violation was exceedingly limited. The very factors appropriately relied on by the judge in granting an injunction against the principal defendants seem to dictate the opposite in the case of Ms. Sharpe. The same is true with respect to Mrs. Kleinman. Her connection with the manipulation consisted of two transactions, a purchase of 100 units and a purchase and sale of 500 units, producing a profit of $228.75 before commissions and not including any loss on the 100 shares she retained.
*101
The trial court’s statement with regard to these two defendants, “We see no reason to believe that, should a similar opportunity arise in the future, they would shy away,” is hardly a finding of likelihood of recurrence. It would make a mockery of language such as that we have recently used in
Bausch & Lomb
to hold that the SEC had met its burden of showing a likelihood of recurrence with respect to these two minor participants concerning whom there was no evidence of prior or subsequent violations. Contrast
SEC
v.
Shapiro,
IV. The standard of culpability required for injunctive relief.
Seizing upon language used by the district court in discussing the liability of Sharpe and another defendant, Guttman, who has not appealed, which we quote in the margin,
11
and findings that Sharpe, Guttman and Marlene Kleinman were in a position to know of the fraudulent scheme and in the exercise of reasonable care should have realized that their actions would further it,
The question whether
Hochfelder
requires us to overrule or qualify our decisions, going back to the well-known
SEC v. Texas Gulf Sulphur Co.,
*102
We likewise find it unnecessary to decide the question here. With respect to the appellants other than Ms. Sharpe and Mrs. Kleinman, the evidence showed action of the most deliberate sort — the creation of phony nominee accounts to create a false appearance that 50,000 BL units had been sold and large-scale manipulation of BL securities. There can be no doubt from the trial court’s findings that these defendants were aware of the circumstances in which they operated and that they acted purposefully and in bad faith. Their behavior comes precisely within the Court’s definition of
scienter
as referring “to a mental state embracing intent to deceive, manipulate, or defraud.”
V. Computation of disgorgement.
Only a few of appellants’ points on the computation of disgorgement require comment. Preliminarily, we are satisfied that the SEC’s charts, while not free of inaccuracy, were reasonably complete and suitable for the purpose to which they were applied.
Defendants complain that the court’s computation of profits and losses ended on March 2, 1973, the last trading day before the SEC suspended trading in BL securities; that they still held substantial amounts of such securities at that time; and that losses after trading was resumed wiped out any profits. We see no reason why, in determining how much should be disgorged in a case where defendants have manipulated securities so as to mulct the public, the court must give them credit for the fact that they had not succeeded in unloading all their purchases at the time when the scheme collapsed. Compare ALI Restatement of Trusts 2d § 213 (1959).
Defendants also complain that the computation took account not only of transactions with the public but also of transactions among themselves. However, the primary purpose of disgorgement is not to compensate investors. Unlike damages, it is a method of forcing a defendant to give up the amount by which he was unjustly enriched, see pp. 95, 96 supra. Disgorgement here was ordered on a several, not a joint basis. It is immaterial that in a particular instance the enrichment came from another party to the scheme rather than from the public.
Finally defendants make numerous claims of mathematical error. The SEC concedes there may have been one whereby a sale of 3250 shares by Kleinman may have been charged to Drucker. It suggests that we affirm the disgorgement as to Drucker to the extent of $24,500 that he concedes to be mathematically correct and direct a remand to consider whether any additional amount should be included. We will do this. Our remand will also permit other defendants to present claims of mathematical (but not of theoretical) error. Hopefully the parties can agree upon an appropriate sum without imposing any further burden on the district judge.
The judgment is modified to exclude Ms. Sharpe from the finding with respect to manipulation and Ms. Sharpe and *103 Mrs. Kleinman from the injunction (but not from disgorgement) 13 and is otherwise affirmed except as to the mathematical errors in the computation of disgorgement, as to which the cause is remanded. No costs.
Notes
. John Feldman, the President and Treasurer, who had been engaged “in the practice of pharmacy as an employee in privately owned pharmacies,” owned 215,000 shares; he was to receive an annual salary of $15,000 commencing on the date when BL acquired an operating property. He is the brother-in-law of defendant Drucker.
. While the court .below did not expressly state that these defendants violated Rule 10b-5 by their participation in the fraudulent closing, the court did state that defendants Sharpe and Guttman had aided and abetted their Rule 10b-5 violation. Since Judge MacMahon’s opinion fully elaborates the factual and legal predicates of such a violation, we think this a clear finding that CCS, Drucker, and Kleinman had indeed breached the rule.
. This provides:
It shall constitute a “fraudulent, deceptive or manipulative act or practice” as used in section 15(c)(2) of the Act, for any broker or dealer participating in any distribution of securities, other than a firm-commitment underwriting, to accept any part of the sale price of any security being distributed unless:
(a) The money or other consideration received is promptly transmitted to the persons entitled thereto; or
(b) If the distribution is being made on an “all-or-none” basis, or on any other basis which contemplates that payment is not to be made to the person on whose behalf the distribution is being made until some further event or contingency occurs, (1) the money or other consideration received is promptly deposited in a separate bank account, as agent or trustee for the persons who have the beneficial interests therein, until the appropriate event or contingency has occurred, and then the funds are promptly transmitted or returned to the persons entitled thereto, or (2) all such funds ate promptly transmitted to a bank which has agreed in writing to hold all such funds in escrow for the persons who have the beneficial interests therein and to transmit or return such funds directly to the persons entitled thereto when the appropriate event or contingency has occurred.
. It is worth noting that if, as urged by the SEC, see point IV infra a finding of scienter is not necessary to warrant issuance of an injunction in a SEC action under Rule 1 Ob-5, a decree *97 in such an action would not preclude a defendant in a private damage suit from litigating that issue, at least if scienter had not been found. Compare ALI, Restatement of Judgments 2d, § 68.1(d) (Tent. Draft No. 1, March 1973).
. Judge MacMahon began his opinion by complaining, quite justifiably in our view, that “the presentation of the case upon the trial was confused, disjointed, unfocused, incoherent and, at times, incomprehensible.”
. The description may not have been improper with respect to the very limited injunction sought in Capital Gains.
. In contrast the Investment Company of Act § 42(e) and the Investment Advisers Act of 1940 § 209(e) say “has engaged” rather than “is about to engage”. As of 1961, the SEC had made four unsuccessful efforts to have the 1933 and 1934 acts amended to correspond with the 1940 acts. On the last of those attempts the Senate committee rejected the amendment as unnecessary in light of existing holdings that a judge should consider past violations as showing “the existence of some cognizable danger of recurrent violation.” 3 Loss, Securities Regulation 1976-77 & n.4 (1961). In 1975, there was another unsuccessful effort. The conference report on the Securities Acts Amendments stated:
Section 21(e) of the Exchange Act authorizes the SEC to seek injunctive relief in the Federal courts in appropriate cases to protect the public interest from securities laws violations. This section was amended by the Senate bill in several respects, two of which require special mention. Section 21(e) was amended (i) by adding the words “has engaged” to the present statutory language “is engaged or is about to engaged in * * * a violation,” and (ii) by changing the present statutory phrase “proper” showing to “such ” showing. The House amendment contained no similar provision.
The conference substitute does not make the noted Senate proposed changes in existing law. The Senate language is dropped without prejudice, the conferees believing that existing law does not require clarification in these respects.
H.R.Rep.No.94-229, 94th Cong., 1st Sess. 102 (1975), U.S.Code Cong. & Admin.News 1975, p. 333. See also ALI, Federal Securities Code § 1515(a), Reporter’s Revision of Text of Tent. Drafts Nos. 1-3 (Oct. 1, 1974).
. It is significant that while this court largely repeated Judge Tenney’s list of factors, it substituted “the likelihood of future violations” for “the fact that defendant has been found guilty of illegal conduct.”
. In an SEC administrative proceeding, In the Matter of S.J. Salmon Co., Inc., Drucker, Kleinman and CCS were charged with manipulating the price of some or all of 26 different securities, see SEC Ex. Act Release No. 11045 (1974). In response to this and another complaint relating to the conduct here at issue, SEC Ex. Act Release No. 11018 (1974), they consented to an order that revoked the broker-dealer registration of CCS and barred Drucker and Kleinman from association with any broker-dealer or investment company or investment adviser, subject to a right to apply to the Commission after two years for leave to become associated in a non-supervisory capacity upon a showing that they would be supervised. SEC Ex. Act Release No. 11782 (1975). We also take notice of the entry, by consent, of a preliminary injunction against Drucker in a subsequent action involving BL securities. SEC v. Drucker, 76 Civ. 2643 (Order of Preliminary Injunction filed Nov. 29, 1976). While defendant denies he consented to the order, both he and his attorney signed the stipulation providing for its entry.
. While there is no evidence here, as there was in Bausch & Lomb, of these defendants’ remorsefulness and concern about their past misconduct, that was simply one factor the court considered there in determining the likelihood of recurrence. The absence of such evidence in this case cannot overcome the Commission’s failure otherwise to establish that likelihood with respect to Ms. Sharpe and Mrs. Kleinman.
. “It has been held that a negligence standard applies in measuring the civil liability of an individual charged with having aided and abetted a securities law violation.”
. The case was not even cited in the Bausch & Lomb opinion.
. Although here disgorgement was sought as ancillary relief in an injunction action, we do not think that when a violation has been established, a failure of the SEC to show the likelihood of recurrence required to justify an injunction should relieve a defendant found to have violated the securities laws from the obligation to disgorge. Also our holding that there was insufficient evidence to find that Ms. Sharpe had engaged in manipulation does not relieve her from liability to disgorge since the fraudulent closing was inextricably linked with the obtaining of the profits ordered to be disgorged.
